McKay Dorota 4
4 · VAPOTHERM INC · Filed Feb 29, 2024
Insider Transaction Report
Form 4
VAPOTHERM INCVAPO
McKay Dorota
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-27+2,275→ 2,275 totalExercise: $0.92Exp: 2033-01-02→ Common Stock (2,275 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−1,300→ 0 totalExercise: $175.12Exp: 2031-12-06→ Common Stock (1,300 underlying) - Award
Stock Option (right to buy)
2024-02-27+1,300→ 1,300 totalExercise: $0.92Exp: 2031-12-06→ Common Stock (1,300 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−1,750→ 0 totalExercise: $25.28Exp: 2032-05-10→ Common Stock (1,750 underlying) - Award
Stock Option (right to buy)
2024-02-27+1,750→ 1,750 totalExercise: $0.92Exp: 2032-05-10→ Common Stock (1,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-02-27−2,275→ 0 totalExercise: $21.60Exp: 2033-01-02→ Common Stock (2,275 underlying)
Holdings
- 21,371
Common Stock
Footnotes (5)
- [F1]Includes 16,746 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan.
- [F2]This option vested as to 25% of the underlying shares on December 6, 2022, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
- [F3]The transactions reported herein reflect a stock option repricing effective February 27, 2024 pursuant to which the exercise price of the repriced options was amended to reduce the exercise price to $0.915 per share, the closing price of the Issuer's common stock on February 27, 2024. There is no change to the expiration dates or the vesting schedule of the repriced options.
- [F4]This option vested as to 25% of the underlying shares on January 1, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.
- [F5]This option vested as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Issuer's applicable equity incentive plan.